Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
-
- Willi Sauerbrei
- Institute for Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
-
- Sheila E Taube
- Cancer Diagnosis Program and Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD
-
- Lisa M McShane
- Cancer Diagnosis Program and Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD
-
- Margaret M Cavenagh
- Cancer Diagnosis Program and Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD
-
- Douglas G Altman
- Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
収録刊行物
-
- JNCI: Journal of the National Cancer Institute
-
JNCI: Journal of the National Cancer Institute 110 (8), 803-811, 2018-06-04
Oxford University Press (OUP)